Skip to content

Read Full Article Here:

AstraZeneca introduced South Korea’s SK Bioscience into the global supply network of its COVID-19 vaccine candidate.

CanSino’s COVID-19 vaccine shows T-cell, antibody responses in phase 2 (study)CanSino Biologics published positive results in The Lancet, showing its adenovirus-based COVID-19 vaccine triggered neutralizing antibody and T-cell responses in a phase 2 trial.

AstraZeneca taps South Korea’s SK Bioscience to help make its COVID-19 vaccine (Reuters)AstraZeneca has inked a deal with South Korea’s SK Bioscience to help make the British pharma’s COVID-19 vaccine candidate, AZD1222.

Recently, the hackers shifted their focus to researchers in COVID-19 vaccines, drugs and diagnostics, according to authorities.

Prosecutors raid GSK Korea’s vaccine division in rumored price-fixing probe (Korea Biomedical Review)Korean prosecutors recently raided GlaxoSmithKline Korea’s vaccine division, an industry source told Korea Biomedical Review.

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *

Related Articles